Immucor Inc. is a leading provider of transfusion and transplantation diagnostic products, that facilitate patient-donor compatibility, on a worldwide scale. Immucor’s mission is to ensure that patients in need of blood, organs, or stem cells get the right match that is safe, accessible, and affordable. Established in 1982, Immucor has a history of innovating to improve transfusion and transplantation medicine and is a valued partner to thousands of healthcare organizations. The result of Immucor’s products are life changing for a patient in need of a transfusion or transplant. As a global company with around 1000 FTEs and revenue of $400 million we are a global leader. Immucor is owned by TPG Capital.